Advertisement

Picture EBD Group BIO-Europe Spring 2021 Digital 650x80
Organisation › Details

Avantium N.V. (Euronext Brussels + Amsterdam: AVTX)

Avantium is a leading technology development company and a forerunner in renewable chemistry. Avantium develops novel technologies based on renewable carbon sources as an alternative to fossilbased chemicals and plastics. The company currently has three technologies at pilot and demonstration phase. The most advanced technology is the YXY® plant-to-plastics–technology that catalytically converts plant-based sugars into a wide range of chemicals and plastics, such as PEF (polyethylene furanoate). Avantium has successfully demonstrated the YXY Technology at its pilot plant in Geleen, the Netherlands. The second technology is the Dawn Technology™ that converts non-food biomass into industrial sugars and lignin in order to transition the chemicals and materials industries to non-fossil resources. In 2018, Avantium opened the DAWN pilot biorefinery in Delfzijl, the Netherlands. The third technology is called Ray Technology™ and catalytically converts industrial sugars to plant-based MEG (mono-ethylene glycol). Avantium is scaling up its Ray Technology™ and the demonstration plant in Delfzijl, the Netherlands opened on November 7, 2019. Next to developing and commercializing renewable chemistry technologies, the company also provides advanced catalysis R&D services and systems to customers in the refinery and chemical industries. Avantium works in partnership with likeminded companies around the globe to create revolutionary renewable chemistry solutions from invention to commercial scale. Avantium’s shares are listed on Euronext Amsterdam and Euronext Brussels (symbol: AVTX). Its offices and headquarters are in Amsterdam, the Netherlands. *

 

Period Start 2008-11-17 existent
  Group Avantium (Group)
  Today Avantium Technologies B.V.
Products Industry chemical services
  Industry 2 industrial biotechnology
Persons Person van Aken, Tom B. (Avantium 200602– CEO)
  Person 2 Roerink, Frank C. H. (Avantium 200705– CFO)
     
Region Region Amsterdam
  Country Netherlands
  Street 29 Zekerinstraat
  City 1014 BV Amsterdam
  Tel +31-20-586-8080
    Address record changed: 2020-12-02
     
Basic data Employees C: 51 to 100 (2016-12-31)
  Currency EUR
  Annual sales 10,491,000 (revenues, consolidated, continuing operations (2016) 2016-12-31)
  Profit 38,137,000 (2016-12-31)
  Cash 14,223,000 (2016-12-31)
     
    * Document for �About Section�: Avantium N.V.. (11/28/19). "Press Release: Avantium Secures Financing Milestone with €25 million EU Funding for FDCA Flagship Plant". Amsterdam.
     
   
Record changed: 2019-12-03

Advertisement

Picture [iito] Plain Stupid Simple 650x80px

More documents for Avantium (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px




» top